193 related articles for article (PubMed ID: 10930993)
21. Role of BCL-2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia.
Baghdassarian N; Bertrand Y; Ffrench P; Duhaut P; Bryon PA; Ffrench M
Br J Haematol; 2000 Apr; 109(1):109-16. PubMed ID: 10848789
[TBL] [Abstract][Full Text] [Related]
22. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
[TBL] [Abstract][Full Text] [Related]
23. Resistance to spontaneous apoptosis in acute myeloid leukaemia blasts is associated with p-glycoprotein expression and function, but not with the presence of FLT3 internal tandem duplications.
Pallis M; Turzanski J; Grundy M; Seedhouse C; Russell N
Br J Haematol; 2003 Mar; 120(6):1009-16. PubMed ID: 12648071
[TBL] [Abstract][Full Text] [Related]
24. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.
Beltinger C; Kurz E; Böhler T; Schrappe M; Ludwig WD; Debatin KM
Blood; 1998 May; 91(10):3943-51. PubMed ID: 9573033
[TBL] [Abstract][Full Text] [Related]
25. BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
Haarman EG; Kaspers GJ; Pieters R; van Zantwijk CH; Broekema GJ; Hählen K; Veerman AJ
Adv Exp Med Biol; 1999; 457():325-33. PubMed ID: 10500808
[TBL] [Abstract][Full Text] [Related]
26. Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy.
Fedasenka UU; Shman TV; Savitski VP; Belevcev MV
Exp Oncol; 2008 Sep; 30(3):248-52. PubMed ID: 18806751
[TBL] [Abstract][Full Text] [Related]
27. Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia.
Casale F; Addeo R; D'Angelo V; Indolfi P; Poggi V; Morgera C; Crisci S; Di Tullio MT
Int J Oncol; 2003 Jan; 22(1):123-8. PubMed ID: 12469194
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous expression of P-glycoprotein and BCL-2 in acute myeloid leukemia blast cells.
Campos L; Oriol P; Sabido O; Guyotat D
Leuk Lymphoma; 1997 Sep; 27(1-2):119-25. PubMed ID: 9373203
[TBL] [Abstract][Full Text] [Related]
29. Membrane transport and apoptosis-related proteins in radiation-associated acute myeloid leukemia following the Chornobyl accident.
Klymenko SV; Ilyenko IN; Golarnik NA; Maznichenko OL; Breier A; Bazyka DA
Gen Physiol Biophys; 2009 Mar; 28(1):63-9. PubMed ID: 19390138
[TBL] [Abstract][Full Text] [Related]
30. Bcl-x(L) is heterogenously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression.
Pallis M; Zhu YM; Russell NH
Leukemia; 1997 Jul; 11(7):945-9. PubMed ID: 9204973
[TBL] [Abstract][Full Text] [Related]
31. Increase in CD95 (Fas/APO-1)-positive CD4+ and CD8+ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena.
Ogawa S; Sakaguchi K; Takaki A; Shiraga K; Sawayama T; Mouri H; Miyashita M; Koide N; Tsuji T
J Gastroenterol Hepatol; 2000 Jan; 15(1):69-75. PubMed ID: 10719750
[TBL] [Abstract][Full Text] [Related]
32. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).
Del Poeta G; Venditti A; Del Principe MI; Maurillo L; Buccisano F; Tamburini A; Cox MC; Franchi A; Bruno A; Mazzone C; Panetta P; Suppo G; Masi M; Amadori S
Blood; 2003 Mar; 101(6):2125-31. PubMed ID: 12424199
[TBL] [Abstract][Full Text] [Related]
33. The effects of high dose methylprednisolone on apoptosis in children with acute lymphoblastic leukemia.
Uçkan D; Yetgin S; Cetin M; Ozyürek E; Okur H; Aslan D; Tuncer M
Clin Lab Haematol; 2003 Feb; 25(1):35-40. PubMed ID: 12542440
[TBL] [Abstract][Full Text] [Related]
34. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
[TBL] [Abstract][Full Text] [Related]
35. Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia.
Tosi P; Visani G; Ottaviani E; Manfroi S; Tura S
Eur J Haematol; 1996 Aug; 57(2):134-41. PubMed ID: 8856090
[TBL] [Abstract][Full Text] [Related]
36. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
[TBL] [Abstract][Full Text] [Related]
37. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study.
Dhooge C; De Moerloose B; Laureys G; Kint J; Ferster A; De Bacquer D; Philippe J; Benoit Y
Br J Haematol; 1999 Jun; 105(3):676-83. PubMed ID: 10354131
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
[TBL] [Abstract][Full Text] [Related]
39. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
40. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
